UB Paderborn / Katalog / Suche / in CDI

Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and Survival

JAMA dermatology (Chicago, Ill.), 2019-06, Vol.155 (6), p.673

2019

Link zum Volltext

Verfügbarkeit prüfen

Neurosarcomatous amelanotic transformation of malignant melanoma presenting as malignant periopheral nerve sheath tumor: Rare case report

Medicine (Baltimore), 2023-06, Vol.102 (25), p.e34034-e34034

2023

Link zum Volltext

Verfügbarkeit prüfen

Re-evaluating the ABCD criteria using a consecutive series of melanomas

Journal of the American Academy of Dermatology, 2020-10, Vol.83 (4), p.1161-1163

2020

Link zum Volltext

Verfügbarkeit prüfen

A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response

Clinical cancer research, 2015-03, Vol.21 (5), p.1019-1027

2015

Link zum Volltext

Verfügbarkeit prüfen

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Nature (London), 2014-11, Vol.515 (7528), p.568-571

2014

Link zum Volltext

Verfügbarkeit prüfen

Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1-Based Immunotherapy

Clinical cancer research, 2019-03, Vol.25 (5), p.1557-1563

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical and dermoscopic features of truly amelanotic plantar melanoma

Melanoma research, 2017-06, Vol.27 (3), p.224-230

2017

Link zum Volltext

Verfügbarkeit prüfen

Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma

Clinical cancer research, 2021-01, Vol.27 (1), p.131-140

2021

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study

Journal of the American Academy of Dermatology, 2019-02, Vol.80 (2), p.448-459

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors

The American journal of surgical pathology, 2020-07, Vol.44 (7), p.893

2020

Link zum Volltext

Verfügbarkeit prüfen

Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement

JAMA : the journal of the American Medical Association, 2016-07, Vol.316 (4), p.429

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of skin cancer screening on melanoma thickness and stage

Journal of the American Academy of Dermatology, 2024-06, Vol.90 (6), p.1280-1282

2024

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma

Journal of the American Academy of Dermatology, 2017-01, Vol.76 (1), p.114-120.e2

2017

Link zum Volltext

Verfügbarkeit prüfen

Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma

Cancer, 2017-04, Vol.123 (8), p.1333-1344

2017

Link zum Volltext

Verfügbarkeit prüfen

PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna

Histopathology, 2021-06, Vol.78 (7), p.1000-1008

2021

Link zum Volltext

Verfügbarkeit prüfen

Dedifferentiated and Undifferentiated Melanomas: Report of 35 New Cases With Literature Review and Proposal of Diagnostic Criteria

The American journal of surgical pathology, 2021-02, Vol.45 (2), p.240

2021

Link zum Volltext

Verfügbarkeit prüfen

An Epidemiologic Analysis of Melanoma Overdiagnosis in the United States, 1975–2017

Journal of investigative dermatology, 2022-07, Vol.142 (7), p.1804-1811.e6

2022

Link zum Volltext

Verfügbarkeit prüfen

The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors

Journal of cutaneous pathology, 2021-09, Vol.48 (9), p.1115-1123

2021

Link zum Volltext

Verfügbarkeit prüfen

DNA methylation-based immune response signature improves patient diagnosis in multiple cancers

The Journal of clinical investigation, 2017-08, Vol.127 (8), p.3090-3102

2017

Link zum Volltext

Verfügbarkeit prüfen

CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire

Clinical cancer research, 2014-05, Vol.20 (9), p.2424-2432

2014

Link zum Volltext

Verfügbarkeit prüfen

Unusual variants of malignant melanoma

Clinics in dermatology, 2009-11, Vol.27 (6), p.564-587

2009

Link zum Volltext

Verfügbarkeit prüfen

Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma

Clinical cancer research, 2019-04, Vol.25 (8), p.2442-2449

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

Clinical cancer research, 2021-01, Vol.27 (1), p.87-95

2021

Link zum Volltext

Verfügbarkeit prüfen

Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

JAMA : the journal of the American Medical Association, 2016-07, Vol.316 (4), p.436

2016

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and Survival

Neurosarcomatous amelanotic transformation of malignant melanoma presenting as malignant periopheral nerve sheath tumor: Rare case report

Re-evaluating the ABCD criteria using a consecutive series of melanomas

A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1-Based Immunotherapy

Clinical and dermoscopic features of truly amelanotic plantar melanoma

Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma

Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study

Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors

Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement

Impact of skin cancer screening on melanoma thickness and stage

Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma

Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma

PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna

Dedifferentiated and Undifferentiated Melanomas: Report of 35 New Cases With Literature Review and Proposal of Diagnostic Criteria

An Epidemiologic Analysis of Melanoma Overdiagnosis in the United States, 1975–2017

The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors

DNA methylation-based immune response signature improves patient diagnosis in multiple cancers

CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire

Unusual variants of malignant melanoma

Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma

Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Aktive Filter

Suchergebnisse filtern